Cosyntropin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0781-3440

2 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cosyntropin (NDC 0781-3440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-strucure (Cosyntropin 01)

Chemical-strucure (Cosyntropin 01)
Chemical structure depiction showing the amino acid sequence of Cosyntropin, a synthetic form of the active ingredient used in the human prescription drug Cosyntropin injection powder, lyophilized for intravenous use by Sandoz Inc.*
FDA Label Image

Carton (Cosyntropin 02)

Carton (Cosyntropin 02)
Packaging label for Cosyntropin for Injection 0.25 mg single dose vials by Sandoz Inc. The lyophilized powder is intended for diagnostic use and can be administered intramuscularly (IM) or intravenously (IV). The package contains 10 single dose vials, each with 0.25 mg of Cosyntropin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.